Nancy Gracin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 40 2nd Ave, Suite 520, Waltham, MA 02451 Phone: 781-487-6000 Fax: 781-497-2978 |
Kenneth A Labresh, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Masspro, 245 Winter Street, Waltham, MA 02451 Phone: 781-419-2782 |
Dr. Rifat B Dweik, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Hope Ave, Suite G07, Waltham, MA 02453 Phone: 781-894-1199 Fax: 781-647-6178 |
Ahmed Mohiuddin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Waverley Oaks Rd, Suite 333, Waltham, MA 02452 Phone: 781-894-8858 Fax: 781-894-8856 |
Dr. Solomon A Gabbay, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 20 Hope Ave, Ste 206, Waltham, MA 02453 Phone: 781-894-2498 Fax: 781-899-5335 |
News Archive
Scientists trying to understand how cancer cells invade healthy tissue have used the fruit fly's metamorphosis from maggot to flying insect as a guide to identify a key molecular signal that may be involved in both processes.
MEDSEEK, a provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced plans to deepen its relationship with long-time partner Trinity Health. It will develop, design and implement the healthcare system's fully integrated online patient experience.
A specialty medical home-providing expert medical care coordinated with attention to social support and mental health-is a promising new approach to patient-centered, cost-effective care for patients with Crohn's disease and ulcerative colitis, according to a special "Future Directions" paper in the May issue of Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America. The journal is published by Wolters Kluwer.
Palatin Technologies, Inc. confirmed today the commencement of a Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity.
A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."
› Verified 2 days ago